Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema
Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema
复制标题
DOI:
10.1016/j.ajo.2005.05.021
复制
发表时间:
2005-10-01
影响因子:
4.2
通讯作者:
Reibaldi, A
中科院分区:
文献类型:
--
作者:
Avitabile, T;Longo, A;Reibaldi, A
PURPOSE: To evaluate the outcome of cystoid macular edema (CME) treated with intravitreal injections of triamcinolone acetonide (TA), macular laser grid photon coagulation (MLG), or both (TA+MLG).DESIGN: Prospective, randomized, interventional, parallel, three,arm clinical trial.METHODS: SETTING: Institutional clinical study. PATIENTS: Fifty-six patients (63 eyes) affected by diabetic or retinal vein occlusion CME. PROCEDURES: Twenty, two eyes received intravitreal injections of 4 mg TA; 21 eyes underwent MLG; and 20 eyes received intravitreal injection of 4 mg TA, and after 3 months, MLG. MAIN OUTCOME MEASURES: Best,corrected visual acuity (VA), central macular thickness (CMT) (by optical coherence tomography), and postoperative complications.RESULTS: Mean follow-up was 9 +/- 2 months (range 6 to 12 months). Baseline VA (logarithm of minimal angle of resolution [logMAR]) and CMT were, respectively, 0.82 +/- 0.19 and 556 +/- 139 mu m microns for the TA group, 0.84 +/- 0.15 and 601 +/- 102 mu m microns for the MLG group, and 0.83 +/- 0.22 and 573 +/- 106 mu m microns for the TA+MLG group (no statistically significant difference among the groups). After the treatment, at 45 days, 3, 6, and 9 months in the TA group, VA had improved (P =.004). by 0.26, 0.25, 0.22, and 0.23 logMAR and CMT had decreased by 37%, 33%, 29%, and 31% (P =